Tübinger Diabetes Mellitus Database (TUEDID)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03658512

Enrollment

1000

Registered

2018-09-05

Start date

2018-02-05

Completion date

2035-02-01

Last updated

2026-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Brief summary

Diabetes mellitus is a widespread disease with increasing prevalence worldwide. Patients with diabetes can develop multiple late complications such as neuropathy, retinopathy, nephropathy and cardiovascular comorbidities. So far, there are no reliable predictive tools or markers to estimate if, when and to what extent a patient with diabetes develops late complications. For the patients quality of life and for health economic reasons an improved risk assessment would be desirable. The prospective TUEDID study will characterize diabetic patients to look out for parameters the predict progression of diabetes and its complications.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Yes

Inclusion criteria

* \>18 years

Exclusion criteria

* no written informed consent

Design outcomes

Primary

Measure	Time frame	Description
Glycemic control (blood glucose)	At enrolment	Assessed as fasting blood glucose and HbA1C
Glycemic control (HbA1C)	At enrolment	Assessed as fasting HbA1C

Countries

Germany

Contacts

CONTACTAndreas Fritsche, MD

andreas.fritsche@med.uni-tuebingen.de+49 7071 29 80687

Outcome results